Structure-guided fragment-based drug discovery at the synchrotron: screening binding sites and correlations with hotspot mapping
Structure-guided drug discovery emerged in the 1970s and 1980s, stimulated by the three-dimensional structures of protein targets that became available, mainly through X-ray crystal structure analysis, assisted by the development of synchrotron radiation sources. Structures of known drugs or inhibit...
Автори: | Thomas, SE, Collins, P, James, RH, Mendes, V, Charoensutthivarakul, S, Radoux, C, Abell, C, Coyne, AG, Floto, RA, Von Delft, F, Blundell, TL |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Royal Society
2019
|
Схожі ресурси
Схожі ресурси
-
Fragment hotspot mapping to identify selectivity-determining regions between related proteins
за авторством: Smilova, MD, та інші
Опубліковано: (2022) -
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
за авторством: Sheikh Mohammed Arif, та інші
Опубліковано: (2022-03-01) -
Hotspots API: a python package for the detection of small molecule binding hotspots and application to structure-based drug design
за авторством: Curran, PR, та інші
Опубліковано: (2020) -
The luminous X-ray hotspot in 4C 74.26: synchrotron or inverse-Compton
emission?
за авторством: Erlund, M, та інші
Опубліковано: (2007) -
Evidence that the maximum electron energy in hotspots of FR II galaxies is not determined by synchrotron cooling
за авторством: Araudo, A, та інші
Опубліковано: (2016)